Figure 3. Differences in the Therapeutic Efficacy of Allogeneic hMSC and Autologous hMSC
The POSEIDON-DCM95 study demonstrated differences in the therapeutic efficacy of allogeneic (Allo, blue) hMSC, and autologous (Auto, red) hMSC. A: Change from baseline in the 6-minute walk distance (6MWD). B: Change from baseline in forced expiratory volume in 1 second. C: Individual patient response in ejection fraction; shaded areas are 95% CI. From Hare et al.95 [CC BY-NC-ND 4.0].